Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.

Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.

Item
http://www.wikidata.org/entity/Q33555775
Tigecycline: first of a new class of antimicrobial agentsRepurposing Clinical Molecule Ebselen to Combat Drug Resistant PathogensIn vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infectionsShort-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens.Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.Cefepime- Induced Non-Convulsive Status Epilepticus (NCSE).Therapeutic drug monitoring of cefepime with micellar electrokinetic capillary chromatography: Assay improvement, quality assurance, and impact on patient drug levels.Activity of linezolid in an in vitro pharmacokinetic-pharmacodynamic model using different dosages and Staphylococcus aureus and Enterococcus faecalis strains with and without a hypermutator phenotype.Monitoring of cefepime in human serum and plasma by micellar electrokinetic capillary chromatography: Improvement of sample preparation and validation by liquid chromatography coupled to mass spectrometry.Pulsatile delivery of clarithromycin alone or in combination with amoxicillin against Streptococcus pneumoniae.An MEKC assay for the therapeutic drug monitoring of cefepime.Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.Use of a bioluminescent Pseudomonas aeruginosa strain within an in vitro microbiological system, as a model of wound infection, to assess the antimicrobial efficacy of wound dressings by monitoring light production.
P2860

Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.

Item
http://www.wikidata.org/entity/Q33555775
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pharmacodynamics of cefepime a ...... armacodynamic infection model.
@ast
Pharmacodynamics of cefepime a ...... armacodynamic infection model.
@en
Pharmacodynamics of cefepime a ...... armacodynamic infection model.
@nl
type
label
Pharmacodynamics of cefepime a ...... armacodynamic infection model.
@ast
Pharmacodynamics of cefepime a ...... armacodynamic infection model.
@en
Pharmacodynamics of cefepime a ...... armacodynamic infection model.
@nl
prefLabel
Pharmacodynamics of cefepime a ...... armacodynamic infection model.
@ast
Pharmacodynamics of cefepime a ...... armacodynamic infection model.
@en
Pharmacodynamics of cefepime a ...... armacodynamic infection model.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Pharmacodynamics of cefepime a ...... armacodynamic infection model.
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.49.1.302-308.2005
P407
P433
P478
P577
P5875
P698
P921
P932